In addition, in our study, it was observed that when the tumor had a high grade, high Ki-67 performance, and belonged to HR-negative/HER2-positive or HR-positive/HER2-positive biological subtypes, a breast pCR was more likely to be obtained after NAC (Table 3). The gene discussed is MKI67; the disease is neoplasm.